Skip to main content

Table 4 The model’s results considering the effect of new and generic drugs alone

From: New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)

  2015 2016 2017 2018 2019
Number of patients 94,727 99,205 103,893 108,804 113,946
New antiretroviral drugs scenario Total ART cost (€) 780,148,483 815,891,938 845,063,294 885,581,470 929,655,763
Per capita ART cost (€) 8,236 8,224 8,134 8,139 8,159
Δ in total cost (€) compared to base case +15,186,448 +26,880,786 +31,666,260 +47,465,974 +66,496,550
% Δ in total cost +2.0 % +3.4 % +3.9 % +5.7 % +7.7 %
Generic drugs scenario Total ART cost (€) 759,981,491 770,436,043 790,580,416 761,583,789 675,775,852
Per capita ART cost (€) 8,023 7,766 7,610 7,000 5,931
Δ in total cost (€) −4,980,545 −18,575,109 −22,816,617 −76,531,708 −187,383,361
% Δ in total cost −0.7 % −2.4 % −2.8 % −9.1 % −21.7 %